Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,865 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of the Rapid ID 32A system for identification of anaerobic Gram-negative bacilli, excluding the Bacteroides fragilis group.
Downes J, King A, Hardie J, Phillips I. Downes J, et al. Among authors: king a. Clin Microbiol Infect. 1999 Jun;5(6):319-326. doi: 10.1111/j.1469-0691.1999.tb00150.x. Clin Microbiol Infect. 1999. PMID: 11856276
A further 97 (21.1%) isolates were correctly identified to species level following the performance of complementary tests recommended by the manufacturer. ...CONCLUSIONS: The Rapid ID 32A system provided a rapid and reliable method for the identification of non-B. f
A further 97 (21.1%) isolates were correctly identified to species level following the performance of complementary tests recommended
Evaluation of the Rapid ID 32A system for the identification of the Bacteroides fragilis group.
King A, Phillips I. King A, et al. Clin Microbiol Infect. 1996;2(2):115-122. doi: 10.1111/j.1469-0691.1996.tb00216.x. Clin Microbiol Infect. 1996. PMID: 11866828
OBJECTIVE: To evaluate the use of a rapid identification system, Rapid ID 32A (bioMérieux), for the identification of clinically important species in the B. fragilis group. ...Rapid ID 32A is a reliable system for the identification of the common species in the B. f …
OBJECTIVE: To evaluate the use of a rapid identification system, Rapid ID 32A (bioMérieux), for the identification of clinically impo …
The Comparative In Vitro Activity of FK-037 (Cefoselis), a New Broad-Spectrum Cephalosporin.
King A, Bethune L, Phillips I. King A, et al. Clin Microbiol Infect. 1995 Sep;1(1):13-17. doi: 10.1111/j.1469-0691.1995.tb00018.x. Clin Microbiol Infect. 1995. PMID: 11866715
FK-037, a new parenteral cephalosporin, was active against clinical isolates of both gram-positive and gram-negative aerobic bacteria. ...
FK-037, a new parenteral cephalosporin, was active against clinical isolates of both gram-positive and gram-negative aerobic bacteria …
Report of the Comité de l'Antibiogramme.
Phillips I, King A. Phillips I, et al. Among authors: king a. Clin Microbiol Infect. 1997;3(5):594. doi: 10.1111/j.1469-0691.1997.tb00322.x. Clin Microbiol Infect. 1997. PMID: 11864196 No abstract available.
Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe.
King A, Downes J, Nord CE, Phillips I; European Study Group. King A, et al. Clin Microbiol Infect. 1999 Jul;5(7):404-416. doi: 10.1111/j.1469-0691.1999.tb00164.x. Clin Microbiol Infect. 1999. PMID: 11853565
Most fusobacteria were inherently resistant to the macrolides, as expected, but resistance to macrolides and a ketolide in other species was uncommon. ...The new compounds, a ketolide (HMR 3647), the glycylcyclines and clinafloxacin, are highly active....
Most fusobacteria were inherently resistant to the macrolides, as expected, but resistance to macrolides and a ketolide in other spec …
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin.
King A, Bathgate T, Phillips I. King A, et al. Clin Microbiol Infect. 2002 Feb;8(2):85-92. doi: 10.1046/j.1469-0691.2002.00347.x. Clin Microbiol Infect. 2002. PMID: 11952721
METHODS: Throat samples were collected before and after treatment and plated as a lawn on Columbia blood agar with an erythromycin E test strip. ...Only a quarter of the patients had no resistant streptococci before treatment started. There were increases in the num …
METHODS: Throat samples were collected before and after treatment and plated as a lawn on Columbia blood agar with an erythromycin E …
European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus.
Zambardi G, Fleurette J, Schito GC, Auckenthaler R, Bergogne-Berezin E, Hone R, King A, Lenz W, Lohner C, Makristhatis A, Marco F, Müller-Serieys C, Nonhoff C, Phillips I, Rohner P, Rotter M, Schaal KP, Struelens M, Viebahn A. Zambardi G, et al. Among authors: king a. Eur J Clin Microbiol Infect Dis. 1996 Sep;15(9):747-9. doi: 10.1007/BF01691964. Eur J Clin Microbiol Infect Dis. 1996. PMID: 8922577
A commercial system for the rapid detection of methicillin-resistant Staphylococcus aureus, the BBL Crystal MRSA test (C-MRSA ID; Becton Dickinson, USA), was evaluated prospectively and compared with a polymerase chain reaction test for the presence of the mecA gene
A commercial system for the rapid detection of methicillin-resistant Staphylococcus aureus, the BBL Crystal MRSA test (C-MRSA ID; Bec
Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study. European Study Group on Antibiotic Resistance (ESGAR).
Dornbusch K, King A, Legakis N. Dornbusch K, et al. Among authors: king a. Scand J Infect Dis. 1998;30(3):281-8. doi: 10.1080/00365549850160945. Scand J Infect Dis. 1998. PMID: 9790138
It is of importance that collaborative national and international studies on the incidence of antibiotic resistance are being performed on a repetitive basis....
It is of importance that collaborative national and international studies on the incidence of antibiotic resistance are being performed on …
In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria.
King A, Bethune L, Phillips I. King A, et al. Antimicrob Agents Chemother. 1993 Apr;37(4):746-9. doi: 10.1128/aac.37.4.746. Antimicrob Agents Chemother. 1993. PMID: 8494370 Free PMC article.
The in vitro activity of MDL 62,879, a new peptide antibiotic that inhibits protein synthesis through an interaction with elongation factor Tu, against a wide range of recent clinical isolates of common aerobic gram-positive and anaerobic organisms was determined. . …
The in vitro activity of MDL 62,879, a new peptide antibiotic that inhibits protein synthesis through an interaction with elongation …
Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
King A, Boothman C, Phillips I. King A, et al. Eur J Clin Microbiol Infect Dis. 1990 Sep;9(9):677-85. doi: 10.1007/BF01964272. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2226498
4,865 results
Jump to page
Feedback